Plainsboro, NJ, United States of America

Dilip J Gole

This inventor holds 1 USPTO granted patent and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dilip J Gole. Retrieved from https://idiyas.com/inventor/dilip-j-gole-turfjnkx

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Dilip J Gole

Introduction

Dilip J Gole is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions containing Ibrutinib. His work has implications for the treatment of various B-cell proliferative disorders.

Latest Patents

Dilip J Gole holds 1 patent related to pharmaceutical compositions containing Ibrutinib. This patent discusses the formulations and processes for preparing these compositions, which are designed for oral ingestion. The compositions can be utilized in treating conditions such as non-Hodgkin lymphoma, Waldenstrom macroglobulinemia, and chronic lymphocytic leukemia, among others.

Career Highlights

Dilip J Gole is associated with Janssen Pharmaceutica NV, where he has been instrumental in advancing pharmaceutical innovations. His expertise in the formulation of Ibrutinib has contributed to the development of effective treatments for serious health conditions.

Collaborations

Dilip has worked alongside notable colleagues such as Maristella Bernini and Sabine Inghelbrecht. Their collaborative efforts have further enhanced the research and development of pharmaceutical compositions.

Conclusion

Dilip J Gole's contributions to the field of pharmaceuticals, particularly through his patent on Ibrutinib compositions, highlight his role as an innovative inventor. His work continues to impact the treatment of various B-cell proliferative disorders, showcasing the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…